Profiel
Michael J.
Dawson is currently the Chief of Staff at Centinela Hospital Medical Center.
Previously, he served as the Chief Medical Officer at Leading Biosciences, Inc. and Palisade Bio, Inc. from 2021 to 2022.
He holds a doctorate degree from the University of Southern California and a graduate degree from the University of California San Diego.
Actieve functies van Michael Dawson
| Bedrijven | Functie | Begin |
|---|---|---|
Centinela Hospital Medical Center
Centinela Hospital Medical Center Hospital/Nursing ManagementHealth Services Operates an acute care hospital | Human Resources Officer | - |
Eerdere bekende functies van Michael Dawson
| Bedrijven | Functie | Einde |
|---|---|---|
| PALISADE BIO, INC. | Hoofd Techniek/Wetenschap/O&O | 11-10-2022 |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Michael Dawson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centinela Hospital Medical Center
Centinela Hospital Medical Center Hospital/Nursing ManagementHealth Services Operates an acute care hospital | Health Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Commercial Services |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
















